Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
anuradha_poonepalli [2023/03/12 02:43] liam | anuradha_poonepalli [2023/03/12 03:31] (current) liam |
---|
{{ ::anuradha_poonepalli.png?200|}} | {{ ::anuradha_poonepalli.png?200|}} |
| |
Dr. **Anuradha Poonepalli** is a pharmaceutical regulatory specialist based in [[Singapore]]. | Dr. **Anuradha Poonepalli** is a pharmaceutical regulatory specialist based in [[Singapore]]. She is a consultant in the Health Products Regulation Group of the [[Health Sciences Authority]] (HSA).((Jasarevic, T. (2020, April 13). //Public statement for collaboration on COVID-19 vaccine development.// World Health Organization. http://archive.today/2020.10.04-153106/https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development)) |
| |
| ===== History ===== |
| |
| ==== Pandemic Preparedness ==== |
| |
| {{ ::27164308_1675020739224181_2721031257246487712_o.jpg?200|}} |
| |
| On January 29-30, 2018, Poonepalli participated as a speaker in a conference titled "DIA and CoRE Conference 2018: Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases", hosted by the [[Drug Information Association]] (DIA) and the [[Duke-NUS Centre of Regulatory Excellence]] (CoRE).((//DIA and CoRE Conference 2018: Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases.// Duke-NuS Medical School. Retrieved August 11, 2018, from http://archive.today/2018.08.11-154129/https://www.duke-nus.edu.sg/core/event/dia-and-core-conference-2018-accelerating-access-innovative-products-%E2%80%93-improving-responses)) |
| |
| ==== COVID-19 ==== |
| |
| Poonepalli participated in a February 11-12, 2020 event titled "2019 novel Coronavirus Global research and innovation forum: towards a research roadmap" co-hosted by the [[World Health Organization]] [[R&D Blueprint]] and [[Global Research Collaboration for Infectious Disease Preparedness]] (GLOPID-R). She and [[Philip Krause]] presented on the topic of "Candidate vaccines R&D".((//2019 novel Coronavirus Global research and innovation forum: towards a research roadmap AGENDA.// (2020). GLOPID-R. https://web.archive.org/web/20230208185417/https://www.glopid-r.org/wp-content/uploads/2020/02/covid-19-global-research-and-innovation-forum-2020-program.pdf)) |
| |
| She was announced as a member of the [[Ministry of Health of Singapore]]'s Expert Committee on COVID-19 Vaccination on November 13, 2020.((kathleen. (2020, November 13). //MOH appoints expert committee to make recommendations for S’pore’s COVID-19 vaccination strategy.// The Online Citizen Asia. http://archive.today/2023.03.12-022741/https://www.theonlinecitizen.com/2020/11/13/moh-appoints-expert-committee-to-make-recommendations-for-spores-covid-19-vaccination-strategy/?amp)) ((Cheong, D., Yang, W., Prof, A., Yin, C., Gascoigne, N., Lim, P., Lian, P., Hospital, S., Lye, D., & Chee, R. //Composition of the Expert Committee on COVID-19 Vaccination.// Ministry of Health. Retrieved March 12, 2023, from https://web.archive.org/web/20221101061806/https://www.moh.gov.sg/docs/librariesprovider5/pressroom/press-releases/annex-expert-comm-rev.pdf)) |
| |
===== External links ===== | ===== External links ===== |
| |
* [[https://www.linkedin.com/in/dr-anuradha-poonepalli-57174715/|LinkedIn]] | * [[https://www.linkedin.com/in/dr-anuradha-poonepalli-57174715/|LinkedIn]] |